Randomized phase II study of treatment with R-CHOP vs Bortezomib-R-CAP for young patients with poor IPI diffuse large B-cell lymphoma. [Estudio fase II aleatorizado de tratamiento de los pacientes jóvenes diagnosticados de linfoma B difuso de célula grande con IPI de alto riesgo con R-CHOP vs Bortezomib-R-CAP].
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bortezomib; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 19 Sep 2018 Biomarkers information updated
- 06 May 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01848132).
- 23 Apr 2013 New trial record